Medicaments containing acyclovir

Medicaments contenant acyclovir


The invention relates to a topical pharmaceutical formulation suitable for use in treating virus infections of the skin and mucosa, and in particular it relates to topical aqueous gel formulations containing 9-(2-hydroxyethoxymethyl)guanine, otherwise known as aciclovir, that exhibit the required stability and allow flux of the compound into the skin.
L'invention concerne une formulation pharmaceutique topique servant à traiter des infections virales de la peau et des muqueuses et, en particulier, des formulations topiques de gel aqueux contenant 9-(2-hydroxyéthoxyméthyl)guanine, connue sous le non d'aciclovir, présentant la stabilité requise et permettant au composé de s'écouler vers l'intérieur de la peau.




Download Full PDF Version (Non-Commercial Use)

Patent Citations (7)

    Publication numberPublication dateAssigneeTitle
    DE-4425322-A1January 25, 1996Merck Patent GmbhVirostatika in hydrophober Gelgrundlage
    EP-0044543-A1January 27, 1982The Wellcome Foundation LimitedTopical formulations of 9-(2-hydroxyethoxymethyl) guanine
    EP-0551626-A1July 21, 1993LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d.Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation
    EP-0614659-A2September 14, 1994Taro Pharmaceutical Industries LimitedPharmaceutical compositions in semisolid form and a device for administration thereof
    EP-0679390-A2November 02, 1995Zyma SAAufsprühbare pharmazeutische Zubereitungen für die topische Anwendung
    EP-0733357-A1September 25, 1996Dompé S.P.A.Pharmaceutical formulations in form of thixotropic gel
    WO-9734607-A1September 25, 1997Glaxo Group LimitedTopical formulations of aciclovir

NO-Patent Citations (0)


Cited By (20)

    Publication numberPublication dateAssigneeTitle
    CN-101925365-BMarch 06, 2013国家科研中心, 巴黎第十一大学具有低水溶解度的治疗性活性物质的纳米颗粒
    EP-1758532-A2March 07, 2007David M. Richliln, George R. DohertyTopische zubereitung und verfahren für die transdermale abgabe und lokalisierung von therapeutischen mitteln
    EP-1758532-A4August 08, 2012David M Richliln, George R DohertyPreparation topique ainsi que procede d'administration transdermique et de localisation d'agents therapeutiques
    EP-1765293-A2March 28, 2007Idexx Laboratories, Inc.Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
    EP-1765293-A4May 30, 2012Idexx Lab IncCompositions pharmaceutiques destinees a l'administration medicamenteuse et methodes de traitement ou de prevention d'etats au moyen de celles-ci
    FR-2837102-A1September 19, 2003Palbian SncAqueous gels containing aciclovir or an antiinflammatory for topical application for the treatment of herpes or inflammations
    FR-2924024-A1May 29, 2009Centre Nat Rech Scient, Univ Paris Sud XiNanoparticules d'actifs therapeutiques de faible solubilite aqueuse
    GB-2370774-BDecember 08, 2004B Ron JohnsonAnti-infective compositions for treating disordered tissue such as cold sores
    JP-2011506276-AMarch 03, 2011セントレ・ナショナル・デ・ラ・レシェルシェ・サイエンティフィーク, ユニヴェルシテ パリ シュド オンズ水溶解度の低い治療剤のナノ粒子
    US-2009270429-A1October 29, 2009Medivir AbAntiviral formulation
    US-8236768-B2August 07, 20123B Pharmaceuticals, Inc.Topical antiviral formulations
    US-8771712-B2July 08, 2014Emisphere Technologies, Inc.Topical administration of acyclovir
    US-8846725-B2September 30, 2014Quadex Pharmaceuticals, LlcHighly penetrating compositions and methods for treating pathogen-induced disordered tissues
    US-8962552-B2February 24, 2015Centre Nationale De Recherche Scientifique, Universite Paris SU XINanoparticles of therapeutic agents having low water solubility
    US-9125911-B2September 08, 2015Quadex Pharmaceuticals, LlcCombined systemic and topical treatment of disordered tissues
    US-9144576-B2September 29, 20153B Pharmaceuticals, Inc.Topical antiviral formulations
    US-9314526-B2April 19, 2016Quadex Pharmaceuticals, LlcHighly penetrating compositions with benzocaine for treating disordered tissues
    WO-03077922-A1September 25, 2003Palbian Societe En Nom CollectifComposition a l'etat de gel aqueux, procede de fabrication et utilisation pour la fabrication d'un medicament, notament antiherpetique
    WO-2009071850-A2June 11, 2009Centre National De La Recherche Scientifique, Universite Paris Sud ViNanoparticles of therapeutic agents having low water solubility
    WO-2009071850-A3November 26, 2009Centre National De La Recherche Scientifique, Universite Paris Sud ViNanoparticles of therapeutic agents having low water solubility